Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Trevo XP ProVue Retriever and Trevo NXT™ ProVue Retriever

K-Number: K203219 · 2020-12-29

ApplicantStryker Neurovascular
Decision Date2020-12-29
Product CodePOL
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

Trevo XP ProVue Retriever and Trevo NXT™ ProVue Retriever is the device name listed in this FDA 510(k) record. The listed applicant is Stryker Neurovascular. It received FDA 510(k) clearance on 2020-12-29 under 510(k) number K203219. The device is classified under product code POL. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Trevo XP ProVue Retriever and Trevo NXT™ ProVue Retriever?

Trevo XP ProVue Retriever and Trevo NXT™ ProVue Retriever is a medical device that received FDA 510(k) clearance on 2020-12-29. The listed applicant is Stryker Neurovascular. The 510(k) number is K203219.

When did Trevo XP ProVue Retriever and Trevo NXT™ ProVue Retriever receive FDA 510(k) clearance?

Trevo XP ProVue Retriever and Trevo NXT™ ProVue Retriever received FDA 510(k) clearance on 2020-12-29, under 510(k) number K203219.

Who is the listed applicant for Trevo XP ProVue Retriever and Trevo NXT™ ProVue Retriever?

The FDA 510(k) record lists Stryker Neurovascular as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Trevo XP ProVue Retriever and Trevo NXT™ ProVue Retriever?

The FDA product code for Trevo XP ProVue Retriever and Trevo NXT™ ProVue Retriever is POL.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT04195568Evaluation of Safety and Effectiveness of Stryker Surpass Evolve™ Flow Diverter SystemACTIVE_NOT_RECRUITING

Other records listing Stryker Neurovascular as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K261889Trevo Trak 21 MicrocatheterPMA P170024Intracranial aneurysm flow diverterK253032AXS Lift Intracranial Base CatheterK252694Target Detachable CoilK251832InZone IST Detachment System; IZDS Connecting CablePMA P180031Intracranial coil-assist stent

View all 27 devices →

Related Devices (Code: POL)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K242676pRESET Delta Thrombectomy Device and pRESET Delta LITE Thrombectomy DevicePhenox LimitedK231539pRESET LITE Thrombectomy DevicePhenox LimitedK223305Trevo NXT ProVue RetrieverStryker NeurovascularK222848pRESET Thrombectomy DevicePhenox LimitedK210502Trevo NXT ProVue RetrieverStryker NeurovascularK203358Solitaire X Revascularization DeviceMicro Therapeutics, Inc. d/b/a ev3 Neurovascular

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑